MEDICINAL RESEARCH REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2022-11-02 ms5000000640975514

有被接收的大佬吗，请问多长时间接收的

31 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2022-06-12 14856b50m82暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
经验分享：投稿后，然后就修改格式一次，然后in review

38 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2023-08-01 Lucky2023 来自四川省

审稿速度:12.0
经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2022-09-17 dedechen

马上6个月，还是in review

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2022-08-19 Yancie JAY

没有ORCID可以投吗

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2021-12-27 ms6000000264964247

引言一般写多少字？

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2021-12-28 msSSSSSD

引言中文章的创新性如何体现？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2024-01-31 ms1000001914122188 来自上海

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：新技术药物发现
经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2023-12-23 1250d11bm60(暂无昵称) 来自浙江省

这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2098101, encodeId=d791209810152, content=有被接收的大佬吗，请问多长时间接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2178201899, createdName=ms5000000640975514, createdTime=Wed Nov 02 20:09:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226030, encodeId=dc2d12260308f, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后，然后就修改格式一次，然后in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Sun Jun 12 20:11:07 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150739, encodeId=d8682150e3946, content=审稿速度:12.0 经验分享：投稿十个月拒稿，拒稿理由是没有找到评审专家，文章投稿量大。中间催稿三次，一次说没有找到评审专家，一次说在评审中，后面第九个月显示换了编辑，发邮件后，说没有合适评审。最后在第十个月拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230421/adeb33fe5b714f0a8fb577ba825f7c91/e882373f4e104adeae042dac78711c17.jpg, createdBy=ea1a1836331, createdName=Lucky2023 , createdTime=Tue Aug 01 09:46:30 CST 2023, time=2023-08-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1250357, encodeId=6240125035e15, content=马上6个月，还是in review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6c81960214, createdName=dedechen, createdTime=Sat Sep 17 22:42:32 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239727, encodeId=38871239e27b2, content=没有ORCID可以投吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Fri Aug 19 14:38:24 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095030, encodeId=9d3610950306a, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095029, encodeId=45c410950299d, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省)]

2023-11-15 ms7000000641553583 来自浙江省

偏重的研究方向：极低出生体重儿;危重新生儿
经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。

39 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务